Targeted Therapies and Developing Precision Medicine in Gastric Cancer

Rille Pihlak1, Caroline Fong1, Naureen Starling1

  • 1Gastrointestinal/Lymphoma Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.

Cancers
|June 28, 2023
PubMed

Insights

Gastric cancer survival remains poor, but new targeted treatments and predictive biomarkers show promise. Precision medicine offers hope for improved outcomes in advanced stages.

Area of Science:

  • Oncology
  • Gastroenterology
  • Pharmacology

Background:

  • Gastric cancer has a poor prognosis, especially in advanced stages.
  • Current targeted treatments are limited to HER2, MSI, and PD-L1 status.
  • Despite advances, effective treatment strategies for many patients are lacking.

Purpose of the Study:

  • To review predictive biomarkers for gastric cancer.
  • To summarize novel targeted treatments under investigation.
  • To explore reasons for conflicting clinical trial results and future directions in precision medicine.

Main Methods:

  • Literature review of previous and ongoing studies.
  • Analysis of predictive biomarkers and targeted therapies.
  • Discussion of clinical trial outcomes and challenges.

Main Results:

  • HER2, MSI, and PD-L1 are established predictive biomarkers.
  • Emerging biomarkers and targeted agents show potential for improved survival.
  • Conflicting trial results highlight the complexity of gastric cancer treatment.

Conclusions:

  • Precision medicine holds significant promise for advancing gastric cancer care.
  • Further research into novel biomarkers and treatments is crucial.
  • Personalized therapeutic strategies are key to improving patient outcomes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
115
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
433